Source: Lung Science Conference 2014 - Lung Inflammation and Immunity



Rating:

Share or cite this content

Citations should be made in the following way:
R. Strieter (Cambridge, United States of America). Early evening session: The new drug discovery paradigm. Lung Science Conference 2014 - Lung Inflammation and Immunity

Member's Comments

No comment yet.

Related content which might interest you: From the bedside: upcoming new clinical strategies Source: International Congress 2016 – Scientific Year in Review 2016 Year: 2016 The new era of diagnostics: will it ever start? Source: International Congress 2019 – Fighting antimicrobial resistance: from prevention to antimicrobial stewardship Year: 2019 Novel capsaicin challenge methodology: a new diagnostic endpoint? Source: Virtual Congress 2020 – Chronic cough: only symptom or disease? Year: 2020 Novel paradigm for inhaled therapies: simulation of drug pharmacokinetic behaviour and effect of disease Source: Eur Respir J 2003; 22: Suppl. 45, 474s Year: 2003 Learning platform for smoking cessation project: From begining to date Source: Annual Congress 2012 - Tobacco cessation and tobacco cessation services Year: 2012 Late Breaking Abstract - Early exploratory use of omic approaches to assess metabolite changes in COPD Source: Virtual Congress 2020 – Chronic lung diseases: novel methods, diagnostics and biomarkers Year: 2020 Clinical use of new and repurposed drugs: the role and contribution of the ERS collaborative projects Source: International Congress 2017 – In the frontline of the fight against tuberculosis Year: 2017 NORDSTAR: paving the way for a new era in asthma research Source: Eur Respir J, 55 (4) 1902476; 10.1183/13993003.02476-2019 Year: 2020 Mannitol: a new development in challenge testing Source: Annual Congress 2012 - New ATS/ERS recommendations for bronchoprovocation challenge testing Year: 2012 From Bench to edside: Development of a drug to treat lung disease from a basic research start Source: Lung Science Conference 2009 - Cell proliferation, Differentiation and Carcinogenesis Year: 2009 Exploring new frontiers: the role of simulation as an educational strategy Source: Breathe 2013; 9: 497-501 Year: 2013 Smoking cessation using innovative techniques: course report Source: Breathe 2015; 11: 255-256 Year: 2015 COVID-19 conundrum: clinical phenotyping based on pathophysiology as a promising approach to guide therapy in a novel illness Source: Eur Respir J, 56 (2) 2002135; 10.1183/13993003.02135-2020 Year: 2020 What next? Basic research, new treatments and a patient-centred approach in controlling tuberculosis Source: Eur Respir Monogr 2018; 82: 414-429 Year: 2018 Session 3: From molecular addiction to therapeutic strategy in NSCLC - Panel discussion Source: New biomarkers, molecules and therapeutic sequences for non small cell lung carcinoma in the era of precision medicine Year: 2019 Precision medicine and personalising therapy in pulmonary hypertension: seeing the light from the dawn of a new era Source: Eur Respir Rev, 27 (148) 180004; 10.1183/16000617.0004-2018 Year: 2018